The basic threshold: BMI 30 or BMI 27 with comorbidity In obesity treatment, GLP-1 is usually considered at BMI 30 or above, or at BMI 27 to 29.9 together with at least one weight-related comorbidity
Exercise three times each week for at least 40 minutes
Gastrointestinal symptoms, particularly nausea and diarrhea, affected a higher percentage of trial participants
By binding to GLP-1 receptors throughout the body, semaglutide enhances insulin secretion in response to meals, suppresses glucagon release, and slows gastric emptyingthe rate at which food moves from the stomach into the small intestine
Fella coaches can also help with dietary strategies that minimize GI discomfort
It produces sharper GH pulses similar to sermorelin but with greater potency